NLS Pharma article

Wastewater can be an important source of knowledge about antimicrobial resistance, and wastewater treatment plants should therefore be part of the emergency response strategy to notify authorities of precursors to potentially dangerous events, states NORCE.

The Center for Protein Design (CPD) at the University of Copenhagen will focus on interdisciplinary collaborations across the university and partnerships in Denmark and internationally. 

Zelluna has developed, scaled and automated its manufacturing process for its TCR-NK cell therapies.

The new study, conducted by researchers at the Chalmers University of Technology, the University of Gothenburg, and the Fraunhofer-Chalmers Centre, shows that antibiotic resistance is more easily transmitted between genetically similar bacteria and mainly occurs in wastewater treatment plants and inside the human body. ​ 

Understanding the science is one thing, but being able to manufacture T-cell therapies at scale is a different matter. TCR-T cell therapies offer a path forward at a fraction of the cost and time of manufacturing a living cell as a product. 

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for NMD670, a novel, oral, small molecule inhibitor of the skeletal muscle-specific chloride ion channel ClC-1, for the treatment of Charcot-Marie-Tooth disease (CMT).